INJUSDT Daily Chart Analysis | Uptrend Brewing at Crucial Level
INJUSDT Daily Chart Analysis | Uptrend Brewing at Crucial Resistance
🔍 Let’s break down the INJ/USDT setup, examining its technical structure and mapping out key opportunities as it gears up for a decisive move.
⏳ Daily Overview
The INJUSDT pair is forming a solid bullish structure, supported by a clear ascending triangle pattern on the daily timeframe. Notably, the 3SMA (7, 25, 99) are crossing to the upside, signaling the early stage of a potential upward trend. This momentum is reinforced by the ascending triangle’s rising trendline, showing steady accumulation and higher lows.
🔺 Bullish Scenario:
Price is consolidating just below the critical resistance at $15.340—a key zone highlighted by multiple rejections in recent months. A confirmed breakout above this level, especially if backed by a surge in volume, would not only trigger a triangle breakout but also complete the weekly candle formation as a bullish hammer, strengthening the bullish case.
If this breakout sustains, short-term targets line up at $20.290, with the long-term roadmap pointing toward $33.970.
📊 Key Highlights:
- 3SMA (7, 25, 99) MA cross signals the beginning of an upward trend.
- Daily ascending triangle points to persistent bullish pressure.
- $15.340 remains a crucial resistance; price has tested and failed here twice before.
- Breakout confirmation (with volume) could ignite a rapid move to $20.290.
- Failure to break may result in another retest of the triangle’s trendline support.
🚨 Conclusion:
All eyes are on the $15.340 resistance. Wait for clear daily close and volume confirmation before entering. A successful breakout aligns with a bullish weekly hammer and could trigger the next phase higher. Beware of fakeouts, as rejection at resistance could send INJUSDT to retest lower trendline zones.
Stay sharp and plan your entries wisely!
🔍 Let’s break down the INJ/USDT setup, examining its technical structure and mapping out key opportunities as it gears up for a decisive move.
⏳ Daily Overview
The INJUSDT pair is forming a solid bullish structure, supported by a clear ascending triangle pattern on the daily timeframe. Notably, the 3SMA (7, 25, 99) are crossing to the upside, signaling the early stage of a potential upward trend. This momentum is reinforced by the ascending triangle’s rising trendline, showing steady accumulation and higher lows.
🔺 Bullish Scenario:
Price is consolidating just below the critical resistance at $15.340—a key zone highlighted by multiple rejections in recent months. A confirmed breakout above this level, especially if backed by a surge in volume, would not only trigger a triangle breakout but also complete the weekly candle formation as a bullish hammer, strengthening the bullish case.
If this breakout sustains, short-term targets line up at $20.290, with the long-term roadmap pointing toward $33.970.
📊 Key Highlights:
- 3SMA (7, 25, 99) MA cross signals the beginning of an upward trend.
- Daily ascending triangle points to persistent bullish pressure.
- $15.340 remains a crucial resistance; price has tested and failed here twice before.
- Breakout confirmation (with volume) could ignite a rapid move to $20.290.
- Failure to break may result in another retest of the triangle’s trendline support.
🚨 Conclusion:
All eyes are on the $15.340 resistance. Wait for clear daily close and volume confirmation before entering. A successful breakout aligns with a bullish weekly hammer and could trigger the next phase higher. Beware of fakeouts, as rejection at resistance could send INJUSDT to retest lower trendline zones.
Stay sharp and plan your entries wisely!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.